Point of Care Network (POCN), an NP and PA network, today released a new survey featuring how 153 NPs and PAs are engaging with life sciences companies in light of the COVID-19 pandemic. Some of the information touched on was the shifting roles and responsibilities of NPs and PAs, ideas to support them to improve patient care, and how they would like to receive communications.
The survey found that COVID-19 has significantly shifted both NPs’ and PAs’ roles and responsibilities. Not surprisingly, 95 percent of the respondents reported that telehealth has had a large impact on their interactions with patients.
Pre-pandemic, in a previous POCN survey, nearly 59 percent of the respondents used conferences to receive information from life sciences companies. In light of newly cancelled events, NPs and PAs are embracing virtual communications even more. In this new survey, the overwhelming majority wants to be reached electronically, through emails, journals, KOL webinars, and are open to virtual rep visits. Finally, the types of conference-style information they want to see most from life sciences companies are prescribing and treatment guidelines, patient assistance programs, disease info, samples, and copay cards.
For the full survey, click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.